These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 11042887

  • 1. [Lipopolysaccharides of Shigella sonnei].
    Borisova EV, Borisov VA.
    Prikl Biokhim Mikrobiol; 2000; 36(5):597-602. PubMed ID: 11042887
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [The immunobiological properties of the lipopolysaccharides of bacteria in the genus Shigella with contrasting virulence and their chemically modified analogs].
    Borisova EV.
    Mikrobiol Z; 1999; 61(4):64-71. PubMed ID: 10565153
    [Abstract] [Full Text] [Related]

  • 4. [Immunosuppressive properties of virulent Shigella strains].
    Borisova EB.
    Mikrobiol Z; 2000; 62(1):64-72. PubMed ID: 11300086
    [Abstract] [Full Text] [Related]

  • 5. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV, Turbyfill KR.
    Vaccine; 2006 Mar 20; 24(13):2290-301. PubMed ID: 16364513
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The role of the structural components of bacterial lipopolysaccharide in its inductive immunosuppressive activity].
    Borisova EV.
    Mikrobiol Z; 1999 Mar 20; 61(6):36-41. PubMed ID: 10707531
    [Abstract] [Full Text] [Related]

  • 8. [Changes in antigenic properties of lipopolysaccharides of Shigella sonnei phase I having lost the virulence due to transposon integration into the invasiveness plasmid PSS120].
    Nikolaeva AI, Nastichkin IA, Romanova IuM, Belova TS, Bondarenko VM, Kabanova EA, Kondrat'eva TK.
    Mol Gen Mikrobiol Virusol; 1990 Aug 20; (8):15-8. PubMed ID: 2172809
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Importance of Shigella virulence in the formation of an immune response in dysentery].
    Borisov VA, Zagornaia NB.
    Mikrobiol Zh (1978); 1980 Aug 20; 42(2):214-8. PubMed ID: 6991890
    [No Abstract] [Full Text] [Related]

  • 13. Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial.
    McKenzie R, Walker RI, Nabors GS, Van De Verg LL, Carpenter C, Gomes G, Forbes E, Tian JH, Yang HH, Pace JL, Jackson WJ, Bourgeois AL.
    Vaccine; 2006 May 01; 24(18):3735-45. PubMed ID: 16095766
    [Abstract] [Full Text] [Related]

  • 14. Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei.
    Formal SB, Oaks EV, Olsen RE, Wingfield-Eggleston M, Snoy PJ, Cogan JP.
    J Infect Dis; 1991 Sep 01; 164(3):533-7. PubMed ID: 1869840
    [Abstract] [Full Text] [Related]

  • 15. IgG response of dysenteric patients to antigens coded by the virulence plasmid of enteroinvasive pathogens.
    Pál T, Brasch G.
    Acta Microbiol Hung; 1987 Sep 01; 34(2):159-63. PubMed ID: 3326389
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.